Rebecca E. Prouty

Array ( [id] => 5452684 [patent_doc_number] => 20090068721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-12 [patent_title] => 'Process for the Production of Recombinant Activated Human Protein C for the Treatment of Sepsis' [patent_app_type] => utility [patent_app_number] => 11/914751 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 2466 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20090068721.pdf [firstpage_image] =>[orig_patent_app_number] => 11914751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5236459 [patent_doc_number] => 20070128616 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-07 [patent_title] => 'Aggrecanase molecules' [patent_app_type] => utility [patent_app_number] => 11/438609 [patent_app_country] => US [patent_app_date] => 2006-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18091 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0128/20070128616.pdf [firstpage_image] =>[orig_patent_app_number] => 11438609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271522 [patent_doc_number] => 20090075298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'METHOD OF ANALYZING ENZYME' [patent_app_type] => utility [patent_app_number] => 11/915050 [patent_app_country] => US [patent_app_date] => 2006-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6901 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075298.pdf [firstpage_image] =>[orig_patent_app_number] => 11915050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051406 [patent_doc_number] => 20070031951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Method for the production of resveratrol in a recombinant bacterial host cell' [patent_app_type] => utility [patent_app_number] => 11/436160 [patent_app_country] => US [patent_app_date] => 2006-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21683 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031951.pdf [firstpage_image] =>[orig_patent_app_number] => 11436160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5888715 [patent_doc_number] => 20060275807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Novel steroid 5alpha-reductase' [patent_app_type] => utility [patent_app_number] => 11/432424 [patent_app_country] => US [patent_app_date] => 2006-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8006 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275807.pdf [firstpage_image] =>[orig_patent_app_number] => 11432424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5687772 [patent_doc_number] => 20060286087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof' [patent_app_type] => utility [patent_app_number] => 11/429422 [patent_app_country] => US [patent_app_date] => 2006-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11093 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20060286087.pdf [firstpage_image] =>[orig_patent_app_number] => 11429422 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5204947 [patent_doc_number] => 20070026428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Combinatorial expression of split caspase molecules' [patent_app_type] => utility [patent_app_number] => 11/416845 [patent_app_country] => US [patent_app_date] => 2006-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 13325 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20070026428.pdf [firstpage_image] =>[orig_patent_app_number] => 11416845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4608632 [patent_doc_number] => 07993887 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-09 [patent_title] => 'Microorganism, lipid-modifying agent, and the method of manufacturing 2-acyl lysophospholipids' [patent_app_type] => utility [patent_app_number] => 11/920856 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2687 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/993/07993887.pdf [firstpage_image] =>[orig_patent_app_number] => 11920856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5784298 [patent_doc_number] => 20060204489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-14 [patent_title] => 'Protein C derivatives' [patent_app_type] => utility [patent_app_number] => 11/397046 [patent_app_country] => US [patent_app_date] => 2006-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8766 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20060204489.pdf [firstpage_image] =>[orig_patent_app_number] => 11397046 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5662324 [patent_doc_number] => 20060252920 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-09 [patent_title] => 'Sequence-determined DNA fragments encoding cyclopropyl isomerase proteins' [patent_app_type] => utility [patent_app_number] => 11/387751 [patent_app_country] => US [patent_app_date] => 2006-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16498 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20060252920.pdf [firstpage_image] =>[orig_patent_app_number] => 11387751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 102300 [patent_doc_number] => 07723097 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Escherichia coli strains that over-produce L-threonine and processes for their production' [patent_app_type] => utility [patent_app_number] => 11/371732 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 15196 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723097.pdf [firstpage_image] =>[orig_patent_app_number] => 11371732 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4595392 [patent_doc_number] => 07981602 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Photoproteins with enhanced bioluminescence and assays using the same' [patent_app_type] => utility [patent_app_number] => 10/587523 [patent_app_country] => US [patent_app_date] => 2006-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 6726 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981602.pdf [firstpage_image] =>[orig_patent_app_number] => 10587523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 121232 [patent_doc_number] => 07709234 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-04 [patent_title] => 'α-1,3-fucosyltransferase' [patent_app_type] => utility [patent_app_number] => 11/276029 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 33 [patent_no_of_words] => 31019 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/709/07709234.pdf [firstpage_image] =>[orig_patent_app_number] => 11276029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 314684 [patent_doc_number] => 07524654 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-28 [patent_title] => 'Isomaltulose synthases, polynucleotides encoding them and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/345363 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 41283 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 184 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/524/07524654.pdf [firstpage_image] =>[orig_patent_app_number] => 11345363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599175 [patent_doc_number] => 07977082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Isomaltulose synthases, polynucleotides encoding them and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/345362 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 41355 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 177 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977082.pdf [firstpage_image] =>[orig_patent_app_number] => 11345362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 122458 [patent_doc_number] => 07704724 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-27 [patent_title] => 'Catalytic buffering systems' [patent_app_type] => utility [patent_app_number] => 11/345679 [patent_app_country] => US [patent_app_date] => 2006-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 4 [patent_no_of_words] => 8231 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704724.pdf [firstpage_image] =>[orig_patent_app_number] => 11345679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5677858 [patent_doc_number] => 20060183214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Modulation of plasma membrane Human Leukocyte Elastase' [patent_app_type] => utility [patent_app_number] => 11/334697 [patent_app_country] => US [patent_app_date] => 2006-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1779 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183214.pdf [firstpage_image] =>[orig_patent_app_number] => 11334697 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4990998 [patent_doc_number] => 20070157339 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Biochemical route to astaxanthin' [patent_app_type] => utility [patent_app_number] => 11/324236 [patent_app_country] => US [patent_app_date] => 2006-01-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7127 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20070157339.pdf [firstpage_image] =>[orig_patent_app_number] => 11324236 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5776687 [patent_doc_number] => 20060105327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Inhibition of the SRC kinase family pathway as a method of treating HBV infection and hepatocellular carcinoma' [patent_app_type] => utility [patent_app_number] => 11/322863 [patent_app_country] => US [patent_app_date] => 2005-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 20871 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20060105327.pdf [firstpage_image] =>[orig_patent_app_number] => 11322863 [rel_patent_id] =>[rel_patent_doc_number] =>)